Zurich Cantonal Bank
ORIC icon

Zurich Cantonal Bank’s Oric Pharmaceuticals ORIC Stock Holding History

Zurich Cantonal Bank’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$196K Buy
+15,432
New +$175K ﹤0.01% 2251
2025
Q4 		– Hold
0
– – – 3230
2025
Q2 		– Sell
-12,626
Closed -$70.5K – 2615
2025
Q1 		$70.5K Sell
12,626
-1,550
-11% -$13.6K ﹤0.01% 2478
2024
Q4 		$114K Buy
14,176
+9,059
+177% +$83.1K ﹤0.01% 2388
2024
Q3 		$52.4K Sell
5,117
-35
-0.7% -$346 ﹤0.01% 2548
2024
Q2 		$36.4K Buy
5,152
+3,188
+162% +$28.5K ﹤0.01% 2568
2024
Q1 		$27K Buy
+1,964
New +$23.3K ﹤0.01% 2612
2022
Q1 		– Sell
-1,620
Closed -$24K – 2807
2021
Q4 		$24K Sell
1,620
-169
-9% -$2.63K ﹤0.01% 2845
2021
Q3 		$37K Hold
1,789
– – ﹤0.01% 2702
2021
Q2 		$32K Buy
1,789
+140
+8% +$3.07K ﹤0.01% 2537
2021
Q1 		$40K Buy
+1,649
New +$52.1K ﹤0.01% 2452

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return